Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Trading Statement

29 Jan 2025 07:00

RNS Number : 0323V
FDM Group (Holdings) plc
29 January 2025
 

29 January 2025

FDM GROUP (HOLDINGS) PLC ("FDM GROUP", "FDM" or "THE GROUP")

YEAR END TRADING UPDATE

FDM Group, a global professional services provider with a focus on Information Technology, today provides a trading update for the year to 31 December 2024, ahead of its full year results, which will be released on 19 March 2025.

Group Trading in the Period and Closing Balance Sheet

The Board anticipates that the Group's financial performance for the year to 31 December 2024 will be in line with its expectations.

Against a continuing backdrop of very challenging market conditions, the Group delivered a resilient performance in 2024. Throughout the period the Board maintained its focus on realigning recruitment, training, Consultant resource, and internal staffing levels to better match with the market conditions; this included a reduced number of training completions during the year (2024: 877 training completions; 2023: 1,338 training completions) and a reduction in internal headcount of approximately 30%.

Revenue for the year to 31 December 2024 is expected to be £258 million, down 23% in comparison to the prior year (2023: £334 million). On a constant currency basis revenue decreased by 21%, or £70 million.

The Group ended the year with 2,578 Consultants placed with clients (2023: 3,892) - a lower level of Consultants deployed than previously anticipated. The UK closed with 1,056 Consultants deployed (2023: 1,411); North America closed with 742 Consultants deployed (2023: 1,322); APAC closed with 524 Consultants deployed (2023: 832); and EMEA closed with 256 Consultants deployed (2023: 327). As at 28 January 2025 the Group has 2,626 Consultants placed with clients.

The Group's balance sheet remains robust with closing cash balances of £41 million (2023: £47 million), and cash conversion strong at 120% (2023: 112%). The Group has no debt.

Outlook

Rod Flavell, Group CEO, commented:

"We anticipate that market conditions will remain uncertain during 2025, and it is difficult to predict when they might demonstrate signs of a sustained improvement. While we continue to see encouraging levels of engagement with clients, it is unclear how soon clients' hiring budgets will be released to enable a recovery in our major end markets. Consequently, the Board will continue to take the appropriate measures to adjust recruitment, training, and staffing levels to align with market conditions and seek to optimise the performance of the Group for all of our stakeholders.

As noted above, we opened 2025 with a lower level of Consultants deployed than we had previously anticipated and this, taken with current market conditions, leads the Board to anticipate that the 2025 full year financial performance may be below its previous expectations.

FDM is a robust and agile business, with a strong balance sheet and experienced management team and Board, operating in fundamentally strong markets. The Board remains confident that our business is well positioned to return to growth as and when market conditions improve."

 

 

 

ENDS

For further information please contact:

FDM Group

Rod Flavell - Chief Executive Officer

Mike McLaren - Chief Financial Officer

Mark Heather - Group Governance Director & Company Secretary

 

 

Tel: +44 (0)20 3056 8240

 

Financial PR

Nick Oborne

 

Tel: +44 (0)7850 127526

 

Forward-Looking Statements

This trading update may contain statements which constitute 'forward-looking statements'. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. Subject to any requirement under the Disclosure Guidance and Transparency Rules or other applicable legislation, regulation or rules, the Group does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Neither shareholders nor prospective shareholders should place undue reliance on forward-looking statements, which speak only as of the date of this Trading Update.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBPMTTMTBTTLA
Date   Source Headline
15th Jan 20241:04 pmRNSDirector/PDMR Shareholding
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20237:00 amRNSDirector/PDMR Shareholding
1st Dec 20239:57 amRNSTotal Voting Rights
20th Nov 20232:22 pmRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSTrading Statement
1st Nov 20237:00 amRNSTotal Voting Rights
25th Oct 20232:16 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSHolding(s) in Company
17th Oct 20233:18 pmRNSBlock Listing Six-Monthly Return
16th Oct 20235:19 pmRNSHolding(s) in Company
12th Oct 20233:46 pmRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSTotal Voting Rights
12th Sep 20233:17 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
14th Aug 202312:11 pmRNSDirector/PDMR Shareholding
8th Aug 20234:05 pmRNSHolding(s) in Company
4th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 202312:59 pmRNSHolding(s) in Company
1st Aug 202310:10 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
19th Jul 20238:56 amRNSDirector Declaration
13th Jul 20234:12 pmRNSDirector/PDMR Shareholding
4th Jul 20236:16 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20237:00 amRNSDirectorate Change
22nd Jun 20232:12 pmRNSHolding(s) in Company
13th Jun 20233:22 pmRNSDirector/PDMR Shareholding
9th Jun 20235:24 pmRNSPDMR Shareholding
5th Jun 20233:32 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSTotal Voting Rights
19th May 20235:33 pmRNSHolding(s) in Company
17th May 20234:00 pmRNSPDMR Shareholding
16th May 20234:19 pmRNSResult of AGM
16th May 20237:00 amRNSAGM Statement
12th May 20232:07 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
14th Apr 20235:23 pmRNSPDMR Shareholding
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
5th Apr 20232:49 pmRNSNotice of AGM
30th Mar 20237:00 amRNSApplication for Block Listing
16th Mar 20233:49 pmRNSHolding(s) in Company
15th Mar 20237:00 amRNSPreliminary Results
14th Mar 202310:02 amRNSDirector/PDMR Shareholding
14th Feb 202312:30 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSYear End Trading Update
12th Jan 202311:06 amRNSDirector/PDMR Shareholding
12th Dec 20225:56 pmRNSDirector/PDMR Shareholding
9th Dec 20224:05 pmRNSHolding(s) in Company
11th Nov 20225:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.